Table 1.

Demographic and Clinical Characteristics*

	Women (n = 21,780)	Men (n = 646,429)	P value
Age (yrs)	59.6 (6.1)	63.9 (6.1)	< 0.0001
A1C (%)†	7.3 (1.6)	7.3 (1.4)	< 0.0001
BMI (mg/kg2)†	34.2 (7.2)	32.6 (6.3)	< 0.0001
Mean SBP (mmHg) ‡	132 (14)	132 (14)	0.27
Mean DBP (mmHg) ‡	74 (9)	75 (9)	< 0.0001
Mean LDL (mg/dl)‡	102 (34)	89 (29)	< 0.0001
Comorbidities (no.)§	4.5 (2.2)	4.3 (2.1)	< 0.0001
Non-concordant conditions (no.)║	2.7 (1.9)	2.2 (1.8)	< 0.0001
Moderate dose statin use (%)	29	32	0.04
High dose statin use (%)¶	23	25	0.17
Ischemic heart disease (%)§	16	23	< 0.0001
Care received in community based clinic (%)	39	49	< 0.0001

A1C hemoglobin A1C, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein

*Values are mean (SD) unless otherwise indicated. ^†Mean value in year prior to study year. ^‡Most recent value from year prior to study year. ^§Comorbidities were identified on the basis of ICD-9 codes listed in the two years prior to the study year. ^║Concordant conditions included those whose treatment is generally related to, or overlaps with, diabetes care and include hypertension, hyperlipidemia, obesity, heart failure, ischemic heart disease, peripheral vascular disease, renal disease, and cerebrovascular disease. All others are considered non-concordant. ^¶Based on the statin dose at start of study year